Modelling during an emergency: The 2009 H1N1 influenza pandemic

Clinical Microbiology and Infection

Volumn 19, Issue 11, 2013, Pages 1014-1022

  Lee, B Y ^a   Haidari, L A ^a   Lee, M S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Emergency; Influenza; Modelling; Pandemic; Policy making; Simulation

Indexed keywords

INFLUENZA VACCINE; PERAMIVIR;

2009 H1N1 INFLUENZA; ANTIVIRAL THERAPY; DISEASE MODEL; DISEASE SEVERITY; EMERGENCY; HEALTH CARE PLANNING; HUMAN; INFECTION PREVENTION; INFLUENZA VACCINATION; INFORMATION PROCESSING; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW;

EMERGENCY; INFLUENZA; MODELLING; PANDEMIC; POLICY-MAKING; SIMULATION;

DECISION SUPPORT TECHNIQUES; EPIDEMIOLOGICAL MONITORING; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MODELS, THEORETICAL; PANDEMICS;

EID: 84885481468     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12284     Document Type: Review

References (72)

1. Quarteroni A. Mathematical models in science and engineering. Not Am Math Soc 2009; 56: 10-19.
2. Allen TT. Introduction to discrete event simulation and agent-based modeling: voting systems, health care, military, and manufacturing. London: Springer, 2011.
3. Nougairede A, Charrel RN, Raoult D. Models cannot predict future outbreaks: A/H1N1 virus, the paradigm. Eur J Epidemiol 2011; 26: 183-186.
4. Iten A, Kaiser L. Influenza A (H1N1) 2009 and uncertainties: lessons from a pandemic. Rev Med Suisse 2010; 6: 704-707.
5. Chan M. WHO Director-General replies to the BMJ. BMJ (Clinical research ed.) 2010; 340: c3463.
6. Lee BY. Digital decision making: computer models and antibiotic prescribing in the twenty-first century. Clin Infect Dis 2008; 46: 1139-1141.
7. Lee BY, Biggerstaff BJ. Screening the United States blood supply for West Nile virus: a question of blood, dollars, and sense. PLoS Med 2006; 3: 168-169.
8. Brockmann Group. Computational quantitative projections for H1N1 flu dynamics in the United States. Northwestern University, 2009. Available from: http://rocs.northwestern.edu/projects/swine_flu/ (cited 24 March 2013).
9. McNeil DG Jr. Predicting flu with the aid of (George) Washington. New York Times 4 May 2009.
10. Balcan D, Hu H, Goncalves B et al. Seasonal transmission potential and activity peaks of the new influenza A(H1N1): a Monte Carlo likelihood analysis based on human mobility. BMC Med 2009; 7: 45. doi:10.1186/1741-7015-7-45
11. Tizzoni M, Bajardi P, Poletto C et al. Real-time numerical forecast of global epidemic spreading: case study of 2009 A/H1N1pdm. BMC Med 2012; 10: 165. doi:10.1186/1741-7015-10-165
12. Wilson K. Revisiting influenza deaths estimates-learning from the H1N1 pandemic. Eur J Pub Health 2012; 22: 7-8.
13. Lipsitch M, Hayden FG, Cowling BJ, Leung GM. How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count. Lancet 2009; 374: 1209-1211.
14. Briand S, Mounts A, Chamberland M. Challenges of global surveillance during an influenza pandemic. Public Health 2011; 125: 247-256.
15. El Emam K, Mercer J, Moreau K, Grava-Gubins I, Buckeridge D, Jonker E. Physician privacy concerns when disclosing patient data for public health purposes during a pandemic influenza outbreak. BMC Public Health 2011; 11: 454. doi:10.1186/1471-2458-11-454
16. Hsieh YH. Age groups and spread of influenza: implications for vaccination strategy. BMC Infect Dis 2010; 10: 106. doi:10.1186/1471-2334-10-106
17. Chao DL, Halloran ME, Obenchain VJ, Longini IM Jr. FluTE, a publicly available stochastic influenza epidemic simulation model. PLoS Comput Biol 2010; 6: e1000656.
18. Ercole A, Taylor BL, Rhodes A, Menon DK. Modelling the impact of an influenza A/H1N1 pandemic on critical care demand from early pathogenicity data: the case for sentinel reporting. Anaesthesia 2009; 64: 937-941.
19. Baker PR, Sun J, Morris J, Dines A. Epidemiologic modeling with FluSurge for pandemic (H1N1) 2009 outbreak, Queensland, Australia. Emerg Infect Dis 2011; 17: 1608-1614.
20. World Health Organization. Mathematical modelling of the pandemic H1N1 2009. Wkly Epidemiol Rec 2009; 84: 341-348.
21. World Health Organization. Global Alert and Response (GAR): Pandemic (H1N1) 2009-2010. Available from: http://www.who.int/csr/disease/swineflu/en/ (cited 27 March 2013).
22. Chan M. World now at the start of 2009 influenza pandemic. World Health Organizationpress release, 2009.
23. Centers for Disease Control and Prevention. The 2009 H1N1 Pandemic: Summary Highlights, April 2009-April 2010 (updated 16 June 2010; cited 27 March 2013 27]. Available from: http://www.cdc.gov/h1n1flu/cdcresponse.htm.
24. Rambhia KJ, Nuzzo J. International progress in vaccine development and distribution. Center for Biosecurity of UPMC. 17 December 2009.
25. Centers for Disease Control and Prevention. New CDC test to detect human infections with the 2009 H1N1 influenza virus authorized for use by FDA. CDC Newsroom: press release, 2010.
26. Centers for Disease Control and Prevention. FluView: National and regional level outpatient illness and viral surveillance 2010. Available from: http://gis.cdc.gov/grasp/fluview/fluportaldashboard.html (cited 27 March 2013).
27. Lee BY, Wiringa AE. The 2009 H1N1 influenza pandemic: a case study of how modeling can assist all stages of vaccine decision-making. Hum Vaccin 2011; 7: 115-119.
28. Van Kerkhove MD, Ferguson NM. Epidemic and intervention modelling-a scientific rationale for policy decisions? Lessons from the 2009 influenza pandemic. Bull World Health Organ 2012; 90: 306-310.
29. Bajardi P, Poletto C, Balcan D et al. Modeling vaccination campaigns and the Fall/Winter 2009 activity of the new A(H1N1) influenza in the Northern Hemisphere. Emerg Health Threats J 2009; 2: e11. doi:10.3134/ehtj.09.011.
30. Fraser C, Donnelly CA, Cauchemez S et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009; 324: 1557-1561.
31. Singh BK, Savill NJ, Ferguson NM, Robertson C, Woolhouse ME. Rapid detection of pandemic influenza in the presence of seasonal influenza. BMC Public Health 2010; 10: 726. doi:10.1186/1471-2458-10-726.
32. Baguelin M, Hoek AJ, Jit M, Flasche S, White PJ, Edmunds WJ. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation. Vaccine 2010; 28: 2370-2384.
33. Perlroth DJ, Glass RJ, Davey VJ, Cannon D, Garber AM, Owens DK. Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States. Clin Infect Dis 2010; 50: 165-174.
34. Pourbohloul B, Ahued A, Davoudi B et al. Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America. Influenza Other Respir Viruses 2009; 3: 215-222.
35. Cauchemez S, Bhattarai A, Marchbanks TL et al. Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza. Proc Natl Acad Sci USA 2011; 108: 2825-2830.
36. Mostaco-Guidolin LC, Bowman CS, Greer AL, Fisman DN, Moghadas SM. Transmissibility of the 2009 H1N1 pandemic in remote and isolated Canadian communities: a modelling study. BMJ Open 2012; 2: e001614. doi:10.1136/bmjopen-2012-001614
37. Merler S, Ajelli M, Pugliese A, Ferguson NM. Determinants of the spatiotemporal dynamics of the 2009 H1N1 pandemic in Europe: implications for real-time modelling. PLoS Comput Biol 2011; 7: e1002205.
38. Birrell PJ, Ketsetzis G, Gay NJ et al. Bayesian modeling to unmask and predict influenza A/H1N1pdm dynamics in London. Proc Natl Acad Sci USA 2011; 108: 18238-18243.
39. Hsieh YH, Fisman DN, Wu J. On epidemic modeling in real time: an application to the 2009 Novel A (H1N1) influenza outbreak in Canada. BMC Res Notes 2010; 3: 283. doi:10.1186/1756-0500-3-283
40. Cauchemez S, Donnelly CA, Reed C et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009; 361: 2619-2627.
41. Lugner AK, van Boven M, de Vries R, Postma MJ, Wallinga J. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis. BMJ (Clinical research ed.) 2012; 345: e4445
42. Lee BY, Brown ST, Cooley PC et al. A computer simulation of employee vaccination to mitigate an influenza epidemic. Am J Prev Med 2010; 38: 247-257.
43. Brouwers L, Cakici B, Camitz M, Tegnell A, Boman M. Economic consequences to society of pandemic H1N1 influenza 2009-preliminary results for Sweden. Euro Surveill 2009; 14: pii=19333.
44. Conway JM, Tuite AR, Fisman DN et al. Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everything. BMC Public Health 2011; 11: 932. doi:10.1186/1471-2458-11-932
45. Dang UJ, Bauch CT. Can interactions between timing of vaccine-altered influenza pandemic waves and seasonality in influenza complications lead to more severe outcomes? PLoS ONE 2011; 6: e23580.
46. Kenah E, Chao DL, Matrajt L, Halloran ME, Longini IM Jr. The global transmission and control of influenza. PLoS ONE 2011; 6: e19515.
47. Lee BY, Brown ST, Korch GW et al. A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic. Vaccine 2010; 28: 4875-4879.
48. Yang Y, Sugimoto JD, Halloran ME et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009; 326: 729-733.
49. Towers S, Chowell G. Impact of weekday social contact patterns on the modeling of influenza transmission, and determination of the influenza latent period. J Theor Biol 2012; 312C: 87-95.
50. House T, Inglis N, Ross JV et al. Estimation of outbreak severity and transmissibility: influenza A(H1N1)pdm09 in households. BMC Med 2012; 10: 117. doi:10.1186/1741-7015-10-117
51. Lempel H, Epstein JM, Hammond RA. Economic cost and health care workforce effects of school closures in the US. PLoS Curr 2009; 1: RRN1051.
52. Lee BY, Brown ST, Cooley P et al. Simulating school closure strategies to mitigate an influenza epidemic. J Public Health Manag Pract 2010; 16: 252-261.
53. Brown ST, Tai JH, Bailey RR et al. Would school closure for the 2009 H1N1 influenza epidemic have been worth the cost?: a computational simulation of Pennsylvania. BMC Public Health 2011; 11: 353. doi:10.1186/1471-2458-11-353
54. Shi P, Keskinocak P, Swann JL, Lee BY. The impact of mass gatherings and holiday traveling on the course of an influenza pandemic: a computational model. BMC Public Health 2010; 10: 778. doi:10.1186/1471-2458-10-778
55. Lam EH, Cowling BJ, Cook AR, Wong JY, Lau MS, Nishiura H. The feasibility of age-specific travel restrictions during influenza pandemics. Theor Biol Med Model 2011; 8: 44. doi:10.1186/1742-4682-8-44
56. H1N WHOINfMMfPI. Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Curr 2009; 1: RRN1135.
57. Lessler J, Reich NG, Cummings DA, Nair HP, Jordan HT, Thompson N. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. N Engl J Med 2009; 361: 2628-2636.
58. Marchbanks TL, Bhattarai A, Fagan RP et al. An outbreak of 2009 pandemic influenza A (H1N1) virus infection in an elementary school in Pennsylvania. Clin Infect Dis 2011; 52(suppl 1): S154-S160.
59. Lee BY, Bacon KM, Donohue JM, Wiringa AE, Bailey RR, Zimmerman RK. From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination. Vaccine 2011; 29: 2149-2158.
60. Khazeni N, Hutton DW, Garber AM, Hupert N, Owens DK. Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med 2009; 151: 829-839.
61. Basta NE, Chao DL, Halloran ME, Matrajt L, Longini IM Jr. Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. Am J Epidemiol 2009; 170: 679-686.
62. Gojovic MZ, Sander B, Fisman D, Krahn MD, Bauch CT. Modelling mitigation strategies for pandemic (H1N1) 2009. CMAJ 2009; 181: 673-680.
63. Sander B, Bauch C, Fisman DN et al. Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Early evidence from the Canadian experience. PLoS Curr 2009; 1: RRN1137.
64. Sander B, Nizam A, Garrison LP Jr, Postma MJ, Halloran ME, Longini IM Jr. Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value Health 2009; 12: 226-233.
65. Lee BY, Brown ST, Cooley P et al. Vaccination deep into a pandemic wave: potential mechanisms for a 'third wave' and the impact of vaccination. Am J Prev Med 2010; 39: e21-e29.
66. Medlock J, Galvani AP. Optimizing influenza vaccine distribution. Science 2009; 325: 1705-1708.
67. Goldstein E, Apolloni A, Lewis B et al. Distribution of vaccine/antivirals and the 'least spread line' in a stratified population. J R Soc Interface 2010; 7: 755-764.
68. Lee BY, Brown ST, Bailey RR et al. The benefits to all of ensuring equal and timely access to influenza vaccines in poor communities. Health Aff (Millwood) 2011; 30: 1141-1150.
69. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60: 1-24.
70. Lee BY, Tai JH, Bailey RR et al. Economic model for emergency use authorization of intravenous peramivir. Am J Manag Care 2011; 17: e1-e9.
71. Dimitrov NB, Goll S, Hupert N, Pourbohloul B, Meyers LA. Optimizing tactics for use of the US antiviral strategic national stockpile for pandemic influenza. PLoS ONE 2011; 6: e16094.
72. Balcan D, Colizza V, Singer AC et al. Modeling the critical care demand and antibiotics resources needed during the Fall 2009 wave of influenza A(H1N1) pandemic. PLoS Curr 2009; 1: RRN1133.